Please login to the form below

Not currently logged in
Email:
Password:

classic Hodgkin's lymphoma

This page shows the latest classic Hodgkin's lymphoma news and features for those working in and with pharma, biotech and healthcare.

Opdivo edges closer to first haematological cancer indication

Opdivo edges closer to first haematological cancer indication

Opdivo edges closer to first haematological cancer indication. EMA begins review of BMS' classic Hodgkin’ s lymphoma inhibitor treatment. ... BMS is seeking approval of Opdivo (nivolumab) for the treatment of classic Hodgkin's lymphoma (cHL) in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics